tweetindex

Samsung Next

@SamsungNext · Global · joined 27 Oct 2014

We back bold and ambitious founders who are pushing the boundaries of AI, intelligent machines, health, consumer services, and frontier tech.

39 762Followers
1 107Following
5 409Posts total
131KViews on collected posts

Against accounts of the same size

5 posts from the last 90 days, next to the 10K–100K follower range. below its peers on both reach and engagement.

Median views1 185this account2 151median for 10K–100K
Reach, %2.98%this account6.48%median for 10K–100K
Engagement, %0.20%this account1.54%median for 10K–100K
MetricThis accountMedian for 10K–100KRatio
Median views per post1 1852 1510.55×
Reach (views ÷ followers)2.98%6.48%0.46×
Engagement rate0.20%1.54%0.13×

Others in this range →   Compare with another account →   How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

74.2K20 Feb
2.3K
21K
6.1K
93821 Feb
91113 Apr
2.3K16 Jun
48717 Jun
1.2K
20.7K18 Aug
93119 Aug

Last 11 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.06%20 Feb
1.41%
0.90%
1.96%
0.53%21 Feb
0.55%13 Apr
0.83%16 Jun
0.21%17 Jun
0.08%
0.30%18 Aug
0.11%19 Aug

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.54%.

What the audience does

Likes85.7%424 in total
Reposts4.0%20 in total
Replies4.6%23 in total
Quotes2.8%14 in total
Bookmarks2.8%14 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Latest posts

Congrats to @somi_synthefy on their $6.5M seed round! https://t.co/n4OlS0BtN3 931 views · 1 likes · 0 reposts · 0 replies 19 Aug 2026 We are announcing our $6.5M seed round led by @Wing_VC, with @haystackvc, @samsungnext, Canonical @ai, @LightscapeVC, and angels from OpenAI, Microsoft, and Meta. We started Synthefy around a simple observation: most data that runs the economy is not text. It is transactions, ht 20.7K views · 39 likes · 11 reposts · 6 replies 18 Aug 2026 Check out what @synthefyinc is up to! 1.2K views · 1 likes · 0 reposts · 0 replies 17 Jun 2026 Find @davidlee in the City of Light at #VivaTech! 487 views · 1 likes · 0 reposts · 0 replies 17 Jun 2026 Thrilled to welcome David Lee, Head of @Samsung Next, to #VivaTech 2026! David was an early backer of some of the most iconic companies in tech. Now he's leading AI, robotics, digital health & AI Services investments at Samsung Next. What's Next? Find out in Paris this June 2.3K views · 12 likes · 5 reposts · 0 replies 16 Jun 2026 Going to #EmTechAI next week? We promise a compelling discussion at From Lab to Launch: Commercializing AI Research with @engineventures , @e14fund , @Cybernetix_VC, and FortyFive Labs. Come join us on Monday, April 20th! RSVP at https://t.co/y9cu5nmca8 911 views · 3 likes · 0 reposts · 1 replies 13 Apr 2026 @SamsungNext @nucleusgenomics Nobody funds fraud quite like @SamsungNext . NOBODY! 938 views · 5 likes · 0 reposts · 0 replies 21 Feb 2026 @SamsungNext @nucleusgenomics This is disappointing. Whoever runs your fund is incompetent. https://t.co/0rNwIVgeSs 6.1K views · 119 likes · 0 reposts · 1 replies 20 Feb 2026 Disappointing. You can be caught dead to rights doing fraud and even have fraudulent claims up on your website, and you'll still be able to find investors who don't care. Nucleus should be shut down and the investors should be regarded as fools. 21K views · 177 likes · 2 reposts · 8 replies 20 Feb 2026 @SamsungNext @nucleusgenomics This is strange because not too long ago Nucleus was caught in a controversy as to whether they had faked embryo screening customer testimonials or provided very inaccurate results to real customers: https://t.co/6dUPx03k7W. On top of lawsuits, plag 2.3K views · 33 likes · 0 reposts · 0 replies 20 Feb 2026 We're proud to make a strategic investment in @nucleusgenomics! Their whole-genome sequencing and predictive platform empowers people to understand and prevent health risks across generations— revolutionizing proactive, software-first healthcare. https://t.co/lTJHlCtxAL 74.2K views · 33 likes · 2 reposts · 7 replies 20 Feb 2026

Similar accounts